Key facts
- Pearl (Decision/Risk Analysis)’s last known valuation is $405.4M (Dec 2024).
- It has raised $91.3M; the latest was Later Stage VC ($80.3M) in Dec 2024.
- Notable investors include Bossa Invest, Valor Equity Partners, Craft Ventures, Left Lane Capital, Crosscut Ventures — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Pearl (Decision/Risk Analysis)
- ·The full record, as it builds
Funding rounds
No funding rounds for Pearl (Decision/Risk Analysis) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pearl (Decision/Risk Analysis)
Developer of an AI-based dental technology designed to identify pathological issues in real-time and with quality precision. The company's technology recognizes and measures dental pathologies, restorative features, and natural anatomy, enabling clinicians, practice owners, labs, and insurers to elevate the efficiency, accuracy, and consistency of dental healthcare.
- Sector
- Healthcare
- HQ
- West Hollywood, CA, United States
- Founded
- 2019
- Employees
- 174
- Website
- hellopearl.com/
- Ownership
- Privately Held (backing)
Pearl (Decision/Risk Analysis) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pearl (Decision/Risk Analysis) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pearl (Decision/Risk Analysis) in its N-PORT filings yet. We sweep new filings monthly.